What Happened?
Palo Alto, CA-based Immune-Onc-Therapeutics Appointed Charlene Liao as President and Chief Executive Officer
About the Company
Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.
About the Person
Charlene Liao is President and Chief Executive Officer at Immune-Onc Therapeutics. Previously, Charlene held various senior HR leadership roles in the industry.
Info Source
News
Short Profile